| SYS | | r032303 |
|---|
| LBL | | ^^^^^naa^^22^^^^^^^^450^ |
|---|
| 005 | | 20130617162517.9 |
|---|
| 100 | | $a 20050322a2005 m y0sloc0103 ba |
|---|
| 101 | 0- | $a eng $d eng |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients $f M. Arslan ... [et al.] |
|---|
| 320 | | $a Res. angl. |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 463 | -1 | $1 001 sllk_un_cat*sg000148_2005_005_001 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 52, no. 1 (2005), p. 43-45 $1 210 $a Bratislava $c Veda |
|---|
| 541 | 1- | $a Porovnanie hladiny erytropoetínu v sére pri chemoterapii a pri liečbe cysplatinou u pacientov s nádorovým ochorením |
|---|
| 606 | 1- | $a erytropoetín $x analógy a deriváty $x analýza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d004921 $9 . |
|---|
| 606 | 1- | $a cisplatina $x aplikácia a dávkovanie $x farmakokinetika $2 mesh $3 sllk_un_auth*d002945 $9 . |
|---|
| 606 | 1- | $a farmakoterapia kombinovaná $2 mesh $3 sllk_un_auth*d004359 $9 . |
|---|
| 606 | 2- | $a nádory $x terapia $2 mesh $3 sllk_un_auth*d009369 $9 . |
|---|
| 606 | 2- | $a anémia $x etiológia $2 mesh $3 sllk_un_auth*d000740 $9 . |
|---|
| 675 | | $a 616.6-085:616.155.194 $v 2. $z slo |
|---|
| 701 | -1 | $a Arslan $b M. $3 sllk_un_auth*p0040264 $4 070 $p Department of medical oncology, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 701 | -1 | $a Evrensel $b T. $3 sllk_un_auth*p0040265 $4 070 $p Department of medical oncology, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 701 | -1 | $a Kurt $b E. $3 sllk_un_auth*p0040266 $4 070 $p Department of medical oncology, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 701 | -1 | $a Demiray $b M. $3 sllk_un_auth*p0040267 $4 070 $p Department of medical oncology, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 701 | -1 | $a Ercan $b I. $3 sllk_un_auth*p0040268 $4 070 $p Department of biostatic, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 701 | -1 | $a Kanat $b O. $3 sllk_un_auth*p0040269 $4 070 $p Department of medical oncology, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 701 | -1 | $a Ali $b R. $3 sllk_un_auth*p0040270 $4 070 $p Department of hematology, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 701 | -1 | $a Ozkan $b A. $3 sllk_un_auth*p0040272 $4 070 $p Department of hematology, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 701 | -1 | $a Manavoglu $b O. $3 sllk_un_auth*p0040273 $4 070 $p Department of medical oncology, Uludag university, Faculty of medicine, Bursa, Turkey |
|---|
| 801 | -0 | $a SK $b BA006 $c 20050322 $g AACR2 |
|---|
